Physician profile
Aaron Long
NPI 1154590479
$811.38
in general payments reported to CMS, 2019-2025
13 companies · $241 in 2025
The $241 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $68.39 · 2022: $146 · 2023: $170 · 2024: $185 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $596.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $273.85 | 2021-2025 | Farxiga |
| Exact Sciences Corporation | $124.96 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amgen INC. | $117.53 | 2023-2025 | Repatha, Otezla, Repatha |
| Corcept Therapeutics | $73.24 | 2025 | Korlym |
| Biogen, INC. | $40.75 | 2021 | |
| Janssen Pharmaceuticals, INC | $38.10 | 2022 | |
| Neuronetics, INC. | $32.63 | 2024 | Neurostar Tms Therapy System |
| Otsuka America Pharmaceutical, INC. | $22.71 | 2024 | Rexulti, Abilify Maintena |
| Pfizer INC. | $20.00 | 2024 | |
| Dexcom, INC. | $19.10 | 2024 | Dexcom G6 Transmitter |
| Abbvie INC. | $17.65 | 2025 | |
| Sanofi Pasteur INC. | $16.71 | 2023 | |
| Glaxosmithkline, LLC. | $14.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.